Corval Sets You on an Optimal Path to Market
Based on decades of commercialization experience, Corval understands the constraints and pressures facing early- to mid-stage biopharma companies. We’ve designed our strategic planning platform to tackle these challenges and guide you from clinic to market.
Created by Industry Experts Who Understand the Challenge
A Lack of Resources, a Lot of Pressure
Corval knows how the complex commercialization planning process can overwhelm a growing company.
A Never-Ending “To-Do” List
Commercialization planning involves cobbling together various tools and resources to tackle the 1,000 things on your list. This fragmented approach is overwhelming.
Corval Knows What It Takes
Keep Everyone Aligned
Corval streamlines the process and organizes all facets of commercialization planning into a single strategic planning space and maintains a “single source of truth” that fosters transparency and collaboration.
Carve Out Room to Think
Not only does Corval simplify the process, its adaptive technology understands and evaluates your unique circumstances.
Corval Knows There Is a Better Way
A single SaaS platform created by experts that aligns to your team’s product and company strategy – that’s how Corval helps emerging companies overcome barriers and chart a clear path to market.
Powered by over 75,000 data points, Corval’s technology assesses your unique situation and creates a customized map of your path to commercialization.
Designed for collaboration and real-time visibility, Corval facilitates building team consensus around internal insights, assumptions, strategic objectives, and decisions.
Informed by decades of experience helping over 100 biopharma companies at all stages forge their path to market.
Freedom to Lead
Corval bears the burden of process and details, freeing you to focus on driving innovation, creating value, and championing patient needs.